Assistant Professor of Medicine, University of Washington

Oncology

Michael Schweizer practices Oncology. He attended Temple University School of Medicine. Michael Schweizer is a published physician. He published 17 publications, including: 'Persistent androgen receptor addiction in castration-resistant prostate cancer.' Michael T. Schweizer is registered with Medicare and accepts Medicare payments.

Publications

---

• Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer.
• Liquid biopsy: Clues on prostate cancer drug resistance.
• Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study.
• Clinical activity of enzalutamide in Docetaxel-naïve and Docetaxel-pretreated patients with metastatic castration-resistant prostate cancer.
• Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone.
• Chemotherapy and its evolving role in the management of advanced prostate cancer.
• Immunotherapy for prostate cancer: recent developments and future challenges.
• The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer.
• Metastasis-free survival is associated with oVerall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.
• Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): Important lessons for future trials.
• Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer.
• From bevacizumab to tasquinimod: angiogenesis as a therapeutic target in prostate cancer.
• Abiraterone acetate: a hat trick of clinical benefits.
• Abiraterone and other novel androgen-directed strategies for the treatment of prostate cancer: a new era of hormonal therapies is born.
• Takotsubo Cardiomyopathy in a Patient With Squamous Cell Esophageal Carcinoma.
• Persistent androgen receptor addiction in castration-resistant prostate cancer.

Schools

---

• Temple University

Conditions Treated

---

• Anemia
• Hodgkin's Disease
• Neutropenia
• Non-Hodgkin's Lymphoma
• View All

Doctors Specialties

---

• Hematology
• Oncology

Accepted Insurances

---

Education

---

• Johns Hopkins University
• University of Chicago
• Temple University School of Medicine

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Kavita B. Kalra, MD This Doctor is OpenDoctor Recommended.
	Dr. Elizabeth M. Jaffee, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Curt I. Civin, MD This Doctor is OpenDoctor Recommended.
	Dr. Samuel R. Denmeade, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Chana Weinstock, MD This Doctor is OpenDoctor Recommended.
	Dr. Satish P. Shanbhag, MD This Doctor is OpenDoctor Recommended.
	Dr. Mya S. Thein, MD This Doctor is OpenDoctor Recommended.
	Dr. Nitya P. Raj, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog